FeesSafety
Pluang+

InspireMD to present CGuard stent trial results at VEITHsymposium 2026 in NYC

Market News
16 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
InspireMD to present CGuard stent trial results at VEITHsymposium 2026 in NYC

InspireMD announced that it will feature multiple talks on its CGuard and CGuard Prime carotid stent systems at VEITHsymposium 2026 in New York City from November 17-21. Presentations will cover key results from the C-GUARDIANS II trial, updates on the ongoing C-GUARDIANS III trial, and three-year follow-up data from 621 asymptomatic patients in the C-GUARDIANS trial. These sessions aim to highlight the benefits and potential of the CGuard stent in stroke prevention and carotid artery procedures. The event gathers leading vascular specialists to discuss the latest advances in vascular disease treatment.

InspireMD's CGuard stent systems are featured in upcoming talks at VEITHsymposium 2026. For readers following the health sector, here is Pluang's market snapshot as of Nov 17, 2026 03:31 WIB: out of 150 US health stocks, 31 rose and 118 fell. Notable movers include NUWE at USD 4.53 (-7.55%), ACB at USD 4.60 (-6.88%) with 100% sell orders, and HRTX at USD 0.29 (-6.57%) with balanced buy/sell activity.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App